Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Reducing Immunogenicity by Design: Approaches to Minimize Immunogenicity of Monoclonal Antibodies
Chantal T. Harris, Sivan Cohen
BioDrugs (2024) Vol. 38, Iss. 2, pp. 205-226
Open Access | Times Cited: 24

Showing 24 citing articles:

Targeting Drug Delivery System to Skeletal Muscles: A Comprehensive Review of Different Approaches
Xiaofang Li, Jintao Xu, Shanshan Yao, et al.
Journal of Cachexia Sarcopenia and Muscle (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 2
In vivo production of engineered ACE2 decoy protects lungs from SARS-CoV-2 infection
Yuta Suzuki, Takayuki Miyazaki, Yoko Ida, et al.
Molecular Therapy — Nucleic Acids (2025) Vol. 36, Iss. 1, pp. 102467-102467
Open Access | Times Cited: 1
Revolutionizing Molecular Design for Innovative Therapeutic Applications through Artificial Intelligence
Ahrum Son, Jongham Park, Woojin Kim, et al.
Molecules (2024) Vol. 29, Iss. 19, pp. 4626-4626
Open Access | Times Cited: 5
Revival of Bioengineered Proteins as Carriers for Nucleic Acids
David C. Scherer, Michael Burger, Jean‐Christophe Leroux
Bioconjugate Chemistry (2024) Vol. 35, Iss. 5, pp. 561-566
Open Access | Times Cited: 4
Sustained efficacy of CRISPR-Cas13b gene therapy for FSHD is challenged by immune response to Cas13b
Afrooz Rashnonejad, Manal Farea, Gholamhossein Amini Chermahini, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
Biosimilars: A Critical Review of Development, Regulatory Landscape, and Clinical Implications
Ankit Monga, Gagan, Pragya Jamwal, et al.
AAPS PharmSciTech (2025) Vol. 26, Iss. 1
Closed Access
Anti-Drug Antibody Response to Therapeutic Antibodies and Potential Mitigation Strategies
Erin L. Howard, Melanie M. Goens, Leonardo Susta, et al.
Biomedicines (2025) Vol. 13, Iss. 2, pp. 299-299
Open Access
Current Review of Monoclonal Antibody Therapeutics in Small Animal Medicine
Jianzhong Wang, Xueying Zhou, Sara T. Elazab, et al.
Animals (2025) Vol. 15, Iss. 4, pp. 472-472
Open Access
IQ Survey Results on Current Industry Practices: Part 2—Quantitative Evaluations of Immunogenicity Assessment
Susan Richards, Insa Winzenborg, Doreen Luedtke, et al.
Clinical Pharmacology & Therapeutics (2025)
Open Access
Advances in nanobody multimerization and multispecificity: from in vivo assembly to in vitro production
Mohammed Al‐Seragi, Yilun Chen, Franck Duong
Biochemical Society Transactions (2025) Vol. 53, Iss. 01
Open Access
A single point mutation on FLT3L-Fc protein increases the risk of immunogenicity
Dan Qin, Qui Phung, Patrick Wu, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Unlocking the potential of in silico approach in designing antibodies against SARS-CoV-2
Tasshitra R. Subramaniam, Siti Aisyah Mualif, Weng Howe Chan, et al.
Frontiers in Bioinformatics (2025) Vol. 5
Open Access
Highly Variable Aggregation and Glycosylation Profiles and Their Roles in Immunogenicity to Protein-Based Therapeutics
Sina Sarsarshahi, Sanghati Bhattacharya, Zeb R. Zacharias, et al.
Journal of Pharmaceutical Sciences (2025), pp. 103771-103771
Closed Access
Advancements in antibody-drug conjugates as cancer therapeutics
Jung Yin Fong, Zhixin Phuna, D. Chong, et al.
Journal of the National Cancer Center (2025)
Open Access
Mechanistic insights into resistance mechanisms to T cell engagers
Liping Cao, Gabrielle Leclercq-Cohen, Christian Klein, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Antibody–Drug Conjugates (ADCs): current and future biopharmaceuticals
Ruili Wang, Baohui Hu, Ziyu Pan, et al.
Journal of Hematology & Oncology (2025) Vol. 18, Iss. 1
Open Access
Bioelectronics based on antibody-conjugated graphene field-effect transistor for response of Staphylococcal enterotoxin B as a biological weapon
Kyung Ho Kim, Eunha Hwang, Jae Woong Jang, et al.
Journal of Hazardous Materials (2025), pp. 138457-138457
Closed Access
New technologies in therapeutic antibody development: The next frontier for treating infectious diseases
Sheila M. Keating, Brett W. Higgins
Antiviral Research (2024) Vol. 227, pp. 105902-105902
Closed Access | Times Cited: 3
Nonclinical immunogenicity risk assessment for knobs-into-holes bispecific IgG 1 antibodies
Wen‐Ting K. Tsai, Yinyin Li, Zhaojun Yin, et al.
mAbs (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 3
Living in LALA land? Forty years of attenuating Fc effector functions
G Hale
Immunological Reviews (2024)
Open Access | Times Cited: 3
Immunogenicity risk assessment and mitigation for engineered antibody and protein therapeutics
Paul J. Carter, Valerie Quarmby
Nature Reviews Drug Discovery (2024) Vol. 23, Iss. 12, pp. 898-913
Closed Access | Times Cited: 3
Optimizing Pharmacological and Immunological Properties of Therapeutic Proteins Through PEGylation: Investigating Key Parameters and Their Impact
João Gonçalves, Paolo Caliceti
Drug Design Development and Therapy (2024) Vol. Volume 18, pp. 5041-5062
Open Access | Times Cited: 3
Immunogenicity of Monoclonal Antibody: Causes, Consequences, and Control Strategies
Ahmad Zafran Amin Asmani, Ahmad Faris Fahmi Zainuddin, Nadhirah Ahmad Azmi Murad, et al.
Pathology - Research and Practice (2024) Vol. 263, pp. 155627-155627
Closed Access | Times Cited: 2
Lectin-modified drug delivery systems – Recent applications in the oncology field
M. Luísa S. Silva
International Journal of Pharmaceutics (2024) Vol. 665, pp. 124685-124685
Closed Access | Times Cited: 1
AI-based IsAb2.0 for antibody design
Tianjian Liang, Ze-Yu Sun, Margaret G. Hines, et al.
Briefings in Bioinformatics (2024) Vol. 25, Iss. 5
Open Access | Times Cited: 1
Page 1

Scroll to top